Question 1.
How many patients were treated by your Trust (for any condition) in the last 3 months with the following drugs:
a. Adalimumab (Amgevita)
b. Adalimumab (Humira)
c. Adalimumab (Hyrimoz)
d. Adalimumab (Idacio)
e. Adalimumab (Imraldi)
Question 2.
How many patients were treated in the last 3 months by the Rheumatology department (for any condition) with the following drugs:
a. Adalimumab (Amgevita)
b. Adalimumab (Humira)
c. Adalimumab (Hyrimoz)
d. Adalimumab (Idacio)
e. Adalimumab (Imraldi)
Question 3.
How many patients were treated in the last 3 months by the Dermatology department (for any condition) with the following drugs:
a. Adalimumab (Amgevita)
b. Adalimumab (Humira)
c. Adalimumab (Hyrimoz)
d. Adalimumab (Idacio)
e. Adalimumab (Imraldi)
